Humacyte Stock Odds of Future Stock Price Finishing Over 29.35

HUMAW Stock  USD 1.79  0.04  2.19%   
Humacyte's future price is the expected price of Humacyte instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Humacyte performance during a given time horizon utilizing its historical volatility. Check out Humacyte Backtesting, Humacyte Valuation, Humacyte Correlation, Humacyte Hype Analysis, Humacyte Volatility, Humacyte History as well as Humacyte Performance.
For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.
  
Please specify Humacyte's target price for which you would like Humacyte odds to be computed.

Humacyte Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Humacyte for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Humacyte can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Humacyte had very high historical volatility over the last 90 days
Humacyte may become a speculative penny stock
Humacyte has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (110.78 M) with profit before overhead, payroll, taxes, and interest of 0.
Humacyte generates negative cash flow from operations

Humacyte Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Humacyte Stock often depends not only on the future outlook of the current and potential Humacyte's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Humacyte's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding103.4 M
Cash And Short Term Investments80.4 M

Humacyte Technical Analysis

Humacyte's future price can be derived by breaking down and analyzing its technical indicators over time. Humacyte Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Humacyte. In general, you should focus on analyzing Humacyte Stock price patterns and their correlations with different microeconomic environments and drivers.

Humacyte Predictive Forecast Models

Humacyte's time-series forecasting models is one of many Humacyte's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Humacyte's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Humacyte

Checking the ongoing alerts about Humacyte for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Humacyte help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Humacyte had very high historical volatility over the last 90 days
Humacyte may become a speculative penny stock
Humacyte has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (110.78 M) with profit before overhead, payroll, taxes, and interest of 0.
Humacyte generates negative cash flow from operations

Additional Tools for Humacyte Stock Analysis

When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.